Search

Your search keyword '"Vallikannan B"' showing total 23 results

Search Constraints

Start Over You searched for: Author "Vallikannan B" Remove constraint Author: "Vallikannan B"
23 results on '"Vallikannan B"'

Search Results

1. Lutein Encapsulated in PLGA–Phospholipid Nano-Carrier Effectively Mitigates Cytokines by Inhibiting Tumor Necrosis Factor TNF-α and Nuclear Factor NF-κB in Mice Retina

2. Fucoxanthin restrains oxidative stress induced by retinol deficiency through modulation of Na(+)Ka(+)-ATPase and antioxidant enzyme activities in rats [corrected] [published erratum appears in EUR J NUTR 2009 Apr;48(3):189].

3. Lutein downregulates retinal vascular endothelial growth factor possibly via hypoxia inducible factor 1 alpha and X-box binding protein 1 expression in streptozotocin induced diabetic rats

4. Chitosan-glycolipid nanocarriers improve the bioavailability of fucoxanthin via up-regulation of PPARγ and SRB1 and antioxidant activity in rat model

5. Lactucaxanthin Regulates the Cascade of Retinal Oxidative Stress, Endoplasmic Reticulum Stress and Inflammatory Signaling in Diabetic Rats.

6. Lutein ameliorates high-fat diet-induced obesity, fatty liver, and glucose intolerance in C57BL/6J mice.

7. Effective inhibition of adipogenesis-mediated inflammation by a macular carotenoid, lutein in vitro.

8. Inhibitory efficacy of lutein on adipogenesis is associated with blockage of early phase regulators of adipocyte differentiation.

10. Fatty acids influence the efficacy of lutein in the modulation of α-crystallin chaperone function: Evidence from selenite induced cataract rat model.

11. Chitosan-oleic acid-sodium alginate a hybrid nanocarrier as an efficient delivery system for enhancement of lutein stability and bioavailability.

12. Lutein upregulates the PGC-1α, NRF1, and TFAM expression by AMPK activation and downregulates ROS to maintain mtDNA integrity and mitochondrial biogenesis in hyperglycemic ARPE-19 cells and rat retina.

13. Enhanced phosphorylation of AMPK by lutein and oxidised lutein that lead to mitochondrial biogenesis in hyperglycemic HepG2 cells.

14. A critical review on anti-angiogenic property of phytochemicals.

15. Fatty acids modulate the efficacy of lutein in cataract prevention: Assessment of oxidative and inflammatory parameters in rats.

16. Biocompatible lutein-polymer-lipid nanocapsules: Acute and subacute toxicity and bioavailability in mice.

17. Dietary Components Affect the Plasma and Tissue Levels of Lutein in Aged Rats with Lutein Deficiency--A Repeated Gavage and Dietary Study.

18. Risk Factors for Nuclear and Cortical Cataracts: A Hospital Based Study.

19. Lutein derived fragments exhibit higher antioxidant and anti-inflammatory properties than lutein in lipopolysaccharide induced inflammation in rats.

20. Dietary and lifestyle risk factors associated with age-related macular degeneration: a hospital based study.

21. Single oral dose of micellar β-carotene containing phospholipids improves β-carotene metabolism and plasma lipids in vitamin A-deficient rats.

22. Lower efficacy in the utilization of dietary ALA as compared to preformed EPA + DHA on long chain n-3 PUFA levels in rats.

23. Fucoxanthin restrains oxidative stress induced by retinol deficiency through modulation of Na(+)K(+)-ATPase [corrected] and antioxidant enzyme activities in rats.

Catalog

Books, media, physical & digital resources